Expertise in
40
conditions

Dr. Jefferson M. Prichard

Hematology | Oncology | Internal Medicine
Martha Jefferson Hospital Oncology
500 Martha Jefferson Dr, 
Charlottesville, VA 
Accepting New Patients
Expertise in
40
conditions
Martha Jefferson Hospital Oncology
500 Martha Jefferson Dr, 
Charlottesville, VA 

Overview

Jefferson Prichard is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia.

Dr. Prichard is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Thrombocytopenia, Multiple Myeloma, and Bone Marrow Aspiration.

Dr. Prichard is board certified in American Board Of Internal Medicine - Hematology - 2027 and American Board Of Internal Medicine - Medical Oncology - 2027. He is actively involved in clinical research, participating in 11 clinical trials. Dr. Prichard is currently accepting new patients.

Graduate Institution

Georgia Institute Of Technology

Residency

University of Virginia Hospitals

Specialties

Hematology
Oncology
Internal Medicine

Licenses

Internal Medicine in VA

Board Certifications

American Board Of Internal Medicine - Hematology - 2027
American Board Of Internal Medicine - Medical Oncology - 2027

Fellowships

Emory University Hospitals - 2011
University of Virginia Hospitals - 2010

Hospital Affiliations

Sentara Rmh Medical Center
University Of Virginia Medical Center
Augusta Health
Page Memorial Hospital, Inc
Sentara Martha Jefferson Hospital
Sentara Medical Group
SQCN Provider

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthKeepers
  • POS
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Piedmont
  • HMO
  • POS
Sentara Healthcare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE ASSISTANCE PROGRAM
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 11 Less Insurance Carriers -

Locations

Martha Jefferson Hospital Oncology
500 Martha Jefferson Dr, Charlottesville, VA 22911
Other Locations
Sentara Martha Jefferson Hematology and Medical Oncology Associates
500 Martha Jefferson Dr, 3rd, Floor, Charlottesville, VA 22911
Sentara Hematology & Oncology Specialists
2008 Health Campus Drive, Harrisonburg, VA 22801

Additional Areas of Focus

Dr. Prichard has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Metastatic Uveal Melanoma

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL)-A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-Small Cell Lung Cancers
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Procedure, Biological, Other
Study Drug: Nivolumab
Study Phase: Phase 3
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST)
Enrollment Status: Active_not_recruiting
Publish Date: August 28, 2026
Intervention Type: Other, Procedure, Biological, Drug
Study Phase: Not Applicable
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2026
Intervention Type: Other, Drug
Study Drug: Erlotinib Hydrochloride
Study Phase: Phase 3
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
A Randomized Phase III Trial for Surgically Resected Early Stage Non-small Cell Lung Cancer: Crizotinib Versus Observation for Patients With Tumors Harboring the Anaplastic Lymphoma Kinase (ALK) Fusion Protein
Enrollment Status: Active_not_recruiting
Publish Date: December 19, 2025
Intervention Type: Other, Drug
Study Drug: Crizotinib
Study Phase: Phase 3
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
A Phase II/III Trial of Neoadjuvant FOLFOX With Selective Use of Combined Modality Chemoradiation Versus Preoperative Combined Modality Chemoradiation for Locally Advanced Rectal Cancer Patients Undergoing Low Anterior Resection With Total Mesorectal Excision (PROSPECT)
Enrollment Status: Unknown
Publish Date: February 02, 2024
Intervention Type: Procedure, Other, Drug
Study Phase: Phase 2/Phase 3
View 4 Less Clinical Trials
Similar Doctors
Expertise in
21
conditions
Dr. Benjamin W. Purow
Hematology | Oncology
Expertise in
21
conditions
Dr. Benjamin W. Purow
Hematology | Oncology
Referral may be required

UVA Health Neuro Oncology

1240 Lee St Fl 3, 
Charlottesville, VA 
 (33.7 miles away)
434-924-9333
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Benjamin Purow is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Purow is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor. Dr. Purow is currently accepting new patients.

Expertise in
3
conditions
Dr. Kimberly P. Dunsmore
Hematology | Oncology
Expertise in
3
conditions
Dr. Kimberly P. Dunsmore
Hematology | Oncology
Referral may be required

UVA Health Heart And Vascular Center Fontaine

500 Ray C Hunt Dr, 
Charlottesville, VA 
 (32.4 miles away)
434-924-0000
Languages Spoken:
English

Kimberly Dunsmore is a Hematologist and an Oncologist practicing medicine in Charlottesville, Virginia. Dr. Dunsmore is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Adult T-Cell Leukemia, Acute Lymphoblastic Leukemia (ALL), Leukemia, and RUNX1 Familial Platelet Disorder.

Expertise in
27
conditions
Expertise in
27
conditions
Referral may be required

UVA Health Emily Couric Clinical Cancer Center

1240 Lee St, 
Charlottesville, VA 
 (32.8 miles away)
434-924-9333
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Craig Portell is a Hematologist practicing medicine in Charlottesville, Virginia. Dr. Portell is highly rated in 27 conditions, according to our data. His clinical expertise encompasses Mantle Cell Lymphoma (MCL), Non-Hodgkin Lymphoma, Marginal Zone Lymphoma (MZL), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Portell is currently accepting new patients.

Frequently Asked Questions about Dr. Jefferson M. Prichard

How do I make an appointment with Dr. Jefferson M. Prichard?

You can book an appointment with Dr. Jefferson M. Prichard by calling their office at 434-654-8390. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jefferson M. Prichard a top-rated expert for Follicular Lymphoma?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jefferson M. Prichard is classified as an Distinguished expert for Follicular Lymphoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jefferson M. Prichard specialize in?

While Dr. Jefferson M. Prichard is a Hematology, they have specific expertise in Follicular Lymphoma, Non-Hodgkin Lymphoma, and Thrombocytopenia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Jefferson M. Prichard accept my insurance?

Dr. Jefferson M. Prichard accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 434-654-8390 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Prichard's expertise for a condition
ConditionClose
    View All 9 Distinguished Conditions
    View All 31 Advanced Conditions
    View All 36 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile